Contents:

Wound Treatments in Mexico Euromonitor International September 2009 List of Contents and Tables Sector Data Table 1 Sales of Wound Treatments by Subsector: Value 2003-2008 Table 2 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008 Table 3 Wound Treatments Company Shares by Value 2004-2008 Table 4 Wound Treatments Brand Shares by Value 2005-2008 Table 5 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013 Table 6 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013 Bayer De México SA De Cv Strategic Direction Key Facts Summary 1 Bayer de México SA de CV: Key Facts Summary 2 Bayer de México SA de CV: Operational Indicators Company Background Production Summary 3 Bayer de México SA de CV: Production Statistics 2007 Competitive Positioning Summary 4 Bayer de México SA de CV: Competitive Position 2008 Boehringer Ingelheim Promeco SA De Cv Strategic Direction Key Facts Summary 5 Boehringer Ingelheim Promeco SA de CV: Key Facts Summary 6 Boehringer Ingelheim Promeco SA de CV: Operational Indicators Company Background Production Competitive Positioning Summary 7 Boehringer Ingelheim Promeco SA de CV: Competitive Position 2008 Farmacias Similares SA De Cv Strategic Direction Key Facts Summary 8 Farmacias Similares SA de CV: Key Facts Summary 9 Farmacias Similares SA de CV: Operational Indicators Company Background Production Competitive Positioning Summary 10 Farmacias Similares SA de CV: Competitive Position 2008 Genomma Lab SA De Cv Strategic Direction Key Facts Summary 11 Genomma Lab SA de CV: Key Facts Summary 12 Genomma Lab SA de CV: Operational Indicators Company Background Production Competitive Positioning Summary 13 Genomma Lab SA de CV: Competitive Position 2008 GlaxoSmithKline Plc Strategic Direction Key Facts Summary 14 GlaxoSmithKline México SA de CV: Key Facts Summary 15 GlaxoSmithKline México SA de CV: Operational Indicators Company Background Production Competitive Positioning Summary 16 GlaxoSmithKline México SA de CV: Competitive Position 2008 Merck-méxico SA Strategic Direction Key Facts Summary 17 Merck-México SA: Key Facts Summary 18 Merck-México SA: Operational Indicators Company Background Competitive Positioning Summary 19 Merck-México SA: Competitive Position 2008 Novartis Farmacéutica SA De Cv Strategic Direction Key Facts Summary 20 Novartis Farmacéutica SA de CV: Key Facts Summary 21 Novartis Farmacéutica SA de CV: Operational Indicators Company Background Production Competitive Positioning Summary 22 Novartis Farmacéutica SA de CV: Competitive Position 2008 Pfizer SA De Cv Strategic Direction Key Facts Summary 23 Pfizer SA de CV: Key Facts Summary 24 Pfizer SA de CV: Operational Indicators Company Background Competitive Positioning Summary 25 Pfizer SA de CV: Competitive Position 2008 Procter & Gamble De México SA De Cv Strategic Direction Key Facts Summary 26 Procter & Gamble de México SA de CV: Key Facts Summary 27 Procter & Gamble de México SA de CV: Operational Indicators Company Background Production Competitive Positioning Summary 28 Procter & Gamble de México SA de CV: Competitive Position 2008 Wyeth SA De Cv Strategic Direction Key Facts Summary 29 Wyeth SA de CV: Key Facts Summary 30 Wyeth SA de CV: Operational Indicators Company Background Production Summary 31 Wyeth SA de CV: Production Statistics 2007 Competitive Positioning Summary 32 Wyeth SA de CV: Competitive Position 2008 Executive Summary Sales of OTC Medication Grow at A Lower Pace Mexican Regulations May Cause Abrupt Changes Many Leading Positions Threatened by Emerging Industry Giant Chained Outlets Are Taking Over the Distribution of Medications Modest Growth Ahead Key Trends and Developments Mexican Regulation Seeking Quality and Affordability in Medications Mexicans Like To Self-medicate the Pharmaceutical Industry Faces Cost Pressures Large Distributors of Medications Are Expanding Throughout Mexico A Giant Is Making the OTC Industry Tremble Market Indicators Table 7 Consumer Expenditure on Health Goods and Medical Services 2003-2008 Table 8 Life Expectancy at Birth 2003-2008 Market Data Table 9 Sales of OTC Healthcare by Sector: Value 2003-2008 Table 10 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008 Table 11 OTC Healthcare Company Shares by Value 2004-2008 Table 12 OTC Healthcare Brand Shares by Value 2005-2008 Table 13 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008 Table 14 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008 Table 15 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013 Table 16 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013 Appendix OTC Registration and Classification Vitamins & Dietary Supplements Registration and Classification Self-medication and Preventative Medicine Generics Definitions Summary 33 Research Sources